Pour cette 24ème édition du Café des Sciences de Boston, événement mensuel regroupant la communauté scientifique et technologique francophone ou francophile de Nouvelle Angleterre, nous avons la joie d’accueillir une delegation de 10 societe du pole de competitivite SYSTEM@TIC.
Deux d’entre elles, MLState et Kayentis, vous presenteront leurs technologies tout-a-fait innovantes et projet de developpement aux Etats-Unis.
Henri Binsztok, 31 ans, a débuté sa carrière par quatre ans en enseignement et recherche en informatique dans les universités Paris 6 et Paris 7. Docteur en informatique, il a initialement étudié la biologie et la physique fondamentale qui l’ont convaincu de l’importance d’une vision globale des systèmes. Il conçoit alors une nouvelle plateforme unifiée pour le développement et l’exécution des services web nommée “One-Pot Applications” (OPA). En 2007, il fonde MLstate pour industrialiser cette technologie. La société passe de 1 à 20 personnes en 2 ans et prépare aujourd’hui le lancement public de la plateforme OPA.
Deuxieme sujet: “Innovation et Convergence…via le papier 2.0?”
Philippe Berna fonde Kayentis en 2003. Il est aussi membre et administrateur du Comite Richelieu, association française des PME innovantes.
Isaac De La Penã, the Head of Internet Strategic Initiatives at Nokia, is an expert in innovation management, corporate ventures and mobile strategy. Originally from Spain, he has an international experience heading multicultural teams on complex projects. His multidisciplinary profile ensures adaptability and top performance in a fast changing business environment. As the head of internet strategic initiatives for Nokia, he is responsible for the strategic transformation of Nokia into an Internet-savvy company, developing the projects, capabilities and resources necessary for the company to compete in a converged mobile 2.0 market. Isaac is also a visiting Scientist at the MIT Media Labs, participating in joint research programs with MIT faculty and students, fostering the creation of an environment that harnesses the power of open innovation at Nokia. He owns two bachelor’s degrees in economics and philosophy and an MBA from the MIT Sloan School of management. He also had strategy training classes at Harvard University with Prof. Clayton Christensen.
Maxime Moulard is CSO for BioCytex, a company that develops quantitative flow cytometry application kits. BioCytex is performing R&D and clinical investigations for major worldwide pharmaceutical companies. Biocytex is currently involved in developing diagnostic tools that can be used in a large spectrum of diseases including cancer, inflammatory diseases and hemostasis. Maxime has been involved in establishing and managing major corporate collaborations and partnerships (Eli Lilly, Sanofi-Aventis) as well as numerous academic and Institutional collaborations.
Valérie Philippon, Director of Publication Strategy and Management at Vertex
Frederic Chereau